BLEEDING PEPTIC ULCER, NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND HELICOBACTER PYLORI INFECTION – A PROSPECTIVE, CONTROLLED, RANDOMIZED STUDY

Autor: Pavel Skok; Igor Križman; Marija Skok
Sprache: Englisch; Slowenisch
Veröffentlicht: 2002
Quelle: Directory of Open Access Journals: DOAJ Articles
Online Zugang: http://vestnik.szd.si/index.php/ZdravVest/article/view/1598
https://doaj.org/toc/1318-0347
https://doaj.org/toc/1581-0224
1318-0347
1581-0224
https://doaj.org/article/18353db3a2d142b398a893057ff9d3a7
https://doaj.org/article/18353db3a2d142b398a893057ff9d3a7
Erfassungsnummer: ftdoajarticles:oai:doaj.org/article:18353db3a2d142b398a893057ff9d3a7

Zusammenfassung

Background. The explanation of peptic ulcer etiology has changed significantly in the past decade after the clarification of the significance of Helicobacter pylori infection. Aim. To evaluate the effectiveness of Helicobacter pylori eradication in patients with hemorrhaging peptic ulcer and patients with peptic ulcer without complications. Study ethics. The study was approved in 1998 by the Medical Ethics Committee of the Republic of Slovenia (No. 90/09/98). Type of study. Prospective, controlled and randomized study, carried out between 1998–2000. Patients and methods. The study included 80 patients (50 male and 30 female, av.age 57.5 years, SD ± 17.1, range 22– 80) in which endoscopy confirmed hemorrhage from peptic ulcer of stomach or duodenum and Helicobacter pylori infection. In all cases endoscopic hemostasis was performed: injection sclerotherapy with diluted adrenalin 1:10,000 and 1% polidocanol or argon plasma coagulation. The control group was made up of 80 patients (50 male and 30 female, av.age 56.8 years, SD ± 16.8, range 19–80) with peptic ulcer of stomach or duodenum and Helicobacter pylori infection. Infection was confirmed by a rapid urease test and histologic investigation of the gastric mucosa. In all cases the recommended drug combinations were used in the treatment of the infection: a proton pump inhibitor, omeprazol (4 weeks), and combination of antibiotics, claritromycin and metronidazole or with regard to the antibiogram (1 week). The therapeutic success was ascertained endoscopically four weeks after inclusion in the study. Infection eradication was confirmed by the rapid urease test and histologic investigation of the gastric mucosa. Results. Four weeks after inclusion in the study the success of infection eradication was 92.5% in the study group, in the control group it was 91.3% (p > 0.05). In 6 patients (7.5%, 6/ 80) from the study group and in 7 (8.8%, 7/80) from the control group we introduced a replacement treatment for the infection. Final treatment of the infection according ...